Mr. Eiden designed, developed, and commercialized 50+ AI approaches in various sectors, including healthcare and life sciences, energy and utilities, travel and transport, oil and gas, telecommunications, defense and financial services.

Prior to joining A&M, Mr. Eiden served as Partner and Global Head of AI/ML at Arthur D. Little, where he established the globally active AI function from the ground up, focusing on AI development and strategy and due diligence of hard- and software assets.

Previously, Mr. Eiden served as CIO for Specific Diagnostics, a California-based medical device company, managing the company’s digital strategy and the development of AI algorithms. Prior to this, he was a postdoctoral researcher at the University of Cambridge, applying AI/ML approaches for early diagnosis of diseases. 

Mr. Eiden earned a Ph.D. in bioinformatics from the University of Trier in Germany.